marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Adaptimmune Therapeutics plc Cash Flow 2011-2024 | ADAP
Annual Cash Flow Adaptimmune Therapeutics plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-141 M | -142 M | 10.7 M | -53.6 M | -113 M | -104 M | -54.3 M | -48.2 M | -29.7 M | - | - | - | - |
Depreciation & Amortization |
9.45 M | 5.27 M | 5.63 M | 6.63 M | 7.17 M | 7.19 M | 5.03 M | 3.13 M | 705 K | 240 K | 47 K | - | - |
Accounts Payables |
8.13 M | 4.75 M | 8.11 M | 6.39 M | 6.36 M | 4.08 M | 8.38 M | 11.4 M | 7.88 M | - | - | - | - |
Accounts Receivables |
821 K | 7.44 M | 752 K | 139 K | - | 192 K | 206 K | 1.48 M | 744 K | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Adaptimmune Therapeutics plc
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -32 M | - | - | - | -37.3 M | - | -144 M | - | -54.4 M | - | -123 M | - | -46.5 M | - | -24.4 M | -8.06 M | 16.9 M | - | -100 M | -70.4 M | -36.2 M | - | -72.7 M | -82.6 M | -47.3 M | - | -33 M | -46.4 M | -28.4 M | - | -50.5 M | -35.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 2.77 M | - | - | - | 1.66 M | - | 4.01 M | - | 1.39 M | - | 4.33 M | - | 1.44 M | - | 5.15 M | 3.58 M | 1.71 M | - | 5.41 M | 3.64 M | 1.83 M | - | 5.25 M | 3.5 M | 1.74 M | - | 1.4 M | 1.04 M | 986 K | - | 779 K | 804 K | 707 K | - | 463 K | 297 K | 1.18 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
9.07 M | 7.51 M | 6.59 M | 8.13 M | 13.9 M | 14.7 M | 5.19 M | 4.75 M | 6.9 M | - | 7.02 M | 8.11 M | 4.78 M | 6.98 M | 4.12 M | 6.39 M | 6.39 M | 6.39 M | 6.39 M | 6.36 M | 6.36 M | 6.36 M | 6.36 M | 4.08 M | 4.08 M | 4.08 M | 4.08 M | 8.38 M | 8.38 M | 8.38 M | 8.38 M | 11.4 M | 11.4 M | 11.4 M | 2.44 M | 7.88 M | 7.88 M | 7.88 M | 7.88 M | - | - | 1.01 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
12.5 M | 2.34 M | 8.4 M | 821 K | 789 K | 2.97 M | 1.72 M | 7.44 M | 1.77 M | - | 1.83 M | 752 K | 1.64 M | 2.16 M | - | 139 K | 139 K | 139 K | - | - | - | 3.81 M | - | 192 K | 192 K | 192 K | 192 K | 206 K | 206 K | 206 K | 206 K | 1.48 M | 1.48 M | 1.48 M | 1 K | 744 K | 744 K | 744 K | 744 K | - | - | 138 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
1.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency